Physical Facial Block

Product NDC: 67226-2330
11-digit product format: 672262330
Labeler code: 67226
Product ID: 67226-2330_57618b68-238d-4a53-b7eb-fb5843f1e510
Type: HUMAN OTC DRUG
Nonproprietary name: ZINC OXIDE, TITANIUM DIOXIDE
Dosage form: CREAM
Route: TOPICAL
Labeler: Vivier Pharma, Inc.
Application: part352
Marketing category: OTC MONOGRAPH NOT FINAL
Marketing start: 2006-08-28
Marketing end: 0000-00-00
Substance: ZINC OXIDE; TITANIUM DIOXIDE
Active strength: 5 g/100mL; g/100mL
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	67226-2330		D	Discontinued by firm		2026-10-12
excluded package	package	67226-2330	67226-2330-6	D	Discontinued by firm		2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	67226-2330-6	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	67226-2330-6	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	67226-2330-6	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	67226-2330-6	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	67226-2330-6	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	67226-2330-6	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	67226-2330-6	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	67226-2330-6	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	67226-2330-6	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	67226-2330-6	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	67226-2330-6	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	67226-2330-6	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	67226-2330-6	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	67226-2330-6	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	67226-2330-6	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	67226-2330-6	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	67226-2330-6	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	67226-2330-6	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	67226-2330-6	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	67226-2330-6	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	67226-2330-6	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		I	Inactivated by FDA	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	67226-2330-6	I	Inactivated by FDA	`110d247fa046…`	`a55b01930146…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
67226-2330-6	2025-01-20	C162847	48780-1	9855e2a2-5118-60a7-e053-dbdaa90a05bd	Physical Facial Block
67226-2330-6	2019-11-27	C162847	48780-1	9855e2a2-5118-60a7-e053-dbdaa90a05bd	Physical Facial Block

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
TITANIUM DIOXIDE	ACTIVE INGREDIENT	15FIX9V2JP	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
ZINC OXIDE	ACTIVE INGREDIENT	SOI2LOH54Z	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
TITANIUM DIOXIDE	ACTIVE MOIETY	15FIX9V2JP	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
ZINC CATION	ACTIVE MOIETY	13S1S8SF37	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
.ALPHA.-TOCOPHEROL ACETATE	INACTIVE INGREDIENT	9E8X80D2L0	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
ALKYL (C12-15) BENZOATE	INACTIVE INGREDIENT	A9EJ3J61HQ	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
AMMONIUM ACRYLOYLDIMETHYLTAURATE	INACTIVE INGREDIENT	KBC00G95HI	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
APPLE	INACTIVE INGREDIENT	B423VGH5S9	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
BIS-PEG/PPG-16/16 PEG/PPG-16/16 DIMETHICONE	INACTIVE INGREDIENT	55A74AJ3KB	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
BUTYLPARABEN	INACTIVE INGREDIENT	3QPI1U3FV8	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
CETOSTEARYL ALCOHOL	INACTIVE INGREDIENT	2DMT128M1S	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
CETYL DIMETHICONE 25	INACTIVE INGREDIENT	U4AS1BW4ZB	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
CITRUS BIOFLAVONOIDS	INACTIVE INGREDIENT	BD70459I50	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
CYCLOMETHICONE	INACTIVE INGREDIENT	NMQ347994Z	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
DIPROPYLENE GLYCOL DIBENZOATE	INACTIVE INGREDIENT	6OA5ZDY41O	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
EICOSYL POVIDONE	INACTIVE INGREDIENT	XQQ9MKE2BJ	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
ETHYLPARABEN	INACTIVE INGREDIENT	14255EXE39	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
GLYCERYL MONOSTEARATE	INACTIVE INGREDIENT	230OU9XXE4	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
GREEN TEA LEAF	INACTIVE INGREDIENT	W2ZU1RY8B0	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
ISOPROPYL TITANIUM TRIISOSTEARATE	INACTIVE INGREDIENT	949E3KBJ1I	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
MEDIUM-CHAIN TRIGLYCERIDES	INACTIVE INGREDIENT	C9H2L21V7U	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
POLYHYDROXYSTEARIC ACID (2300 MW)	INACTIVE INGREDIENT	YXH47AOU0F	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
POLYOXYL 20 CETOSTEARYL ETHER	INACTIVE INGREDIENT	YRC528SWUY	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
POLYSORBATE 20	INACTIVE INGREDIENT	7T1F30V5YH	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
PPG-15 STEARYL ETHER BENZOATE	INACTIVE INGREDIENT	80D2J6361M	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
SODIUM ASCORBYL PHOSPHATE	INACTIVE INGREDIENT	836SJG51DR	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
SUGARCANE	INACTIVE INGREDIENT	81H2R5AOH3	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	PHYSICAL FACIAL BLOCK SPF 30 (ZINC OXIDE, TITANIUM DIOXIDE) CREAM [VIVIER PHARMA, INC.]	1

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
SOI2LOH54Z	ZINC OXIDE	1314-13-2	ZINC OXIDE
15FIX9V2JP	TITANIUM DIOXIDE	13463-67-7	TITANIUM DIOXIDE

Physical Facial Block

NDC auxiliary status#

Observed NDC auxiliary status history#

Reported adverse events (FAERS/openFDA)#

FDA-Initiated Inactive NDC Indexing#

DailyMed Socrata Ingredients#

Related Records#

Related UNII Ingredients#

Related DailyMed Labels#